These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 30689553)
1. Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer. Ji B; Huang Y; Gu T; Zhang L; Li G; Zhang C Cancer Biomark; 2019; 24(2):249-255. PubMed ID: 30689553 [TBL] [Abstract][Full Text] [Related]
2. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
3. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
5. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
6. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients. Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101 [TBL] [Abstract][Full Text] [Related]
8. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
9. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer. Li S; Zhang M; Zhang H; Hu K; Cai C; Wang J; Shi L; Ma P; Xu Y; Zheng P Clin Chim Acta; 2020 Feb; 501():252-257. PubMed ID: 31730812 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566 [TBL] [Abstract][Full Text] [Related]
12. High Expression of Serum UCA1 may be a Potential Biomarker for Clinical Diagnosis of Gastric Cancer. Shan L; Liu C; Ma C Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532112 [TBL] [Abstract][Full Text] [Related]
13. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study. Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332 [TBL] [Abstract][Full Text] [Related]
14. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
15. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer. Jing R; Cui M; Ju S; Pan S Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255307 [TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
17. Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer. Wu J; Li G; Wang Z; Yao Y; Chen R; Pu X; Wang J Dis Markers; 2015; 2015():435656. PubMed ID: 26063956 [TBL] [Abstract][Full Text] [Related]
18. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer. Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960 [TBL] [Abstract][Full Text] [Related]
19. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614 [TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer. Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]